| Original language | English |
|---|---|
| Pages (from-to) | 7-8 |
| Number of pages | 2 |
| Journal | Clinical and Experimental Neuroimmunology |
| Volume | 10 |
| Issue number | 1 |
| DOIs |
|
| Publication status | Published - Feb 2019 |
All Science Journal Classification (ASJC) codes
- Neuroscience (miscellaneous)
- Immunology
- Immunology and Microbiology (miscellaneous)
- Clinical Neurology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Anti-plexin D1 antibodies are a novel biomarker for immune-mediated neuropathic pain. / Fujii, Takayuki; Yamasaki, Ryo; Kira, Jun ichi.
In: Clinical and Experimental Neuroimmunology, Vol. 10, No. 1, 02.2019, p. 7-8.Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - Anti-plexin D1 antibodies are a novel biomarker for immune-mediated neuropathic pain
AU - Fujii, Takayuki
AU - Yamasaki, Ryo
AU - Kira, Jun ichi
N1 - Funding Information: This study was supported in part by Health and Labor Sciences Research Grants for Intractable Diseases (H24-Shinkei-Kin-Ippan-001, H26-Nanchitou [Nan]-Ippan-074, and H29-Nanchitou [Nan]-Ippan-043) from the Ministry of Health, Labor and Welfare, Japan; ?Glial Assembly? Grants-in-Aid for Scientific Research on Innovative Areas (MEXT KAKENHI Grant Numbers 25117001 and 25117012) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a Grant-in-Aid for Scientific Research (A) (JSPS KAKENHI Grant Number 16H02657); Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI Grant Number 16K09694); and Grant-in-Aid for Young Scientists (B) (JSPS KAKENHI Grant Number 15K19492) from the Japan Society for the Promotion of Science. We thank Mitchell Arico from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript. Funding Information: This study was supported in part by Health and Labor Sciences Research Grants for Intractable Funding Information: Diseases (H24-Shinkei-Kin-Ippan-001, H26-Nanchi-tou [Nan]-Ippan-074, and H29-Nanchitou [Nan]-Ippan-043) from the Ministry of Health, Labor and Welfare, Japan; “Glial Assembly” Grants-in-Aid for Scientific Research on Innovative Areas (MEXT KAKENHI Grant Numbers 25117001 and 25117012) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a Grant-in-Aid for Scientific Research (A) (JSPS KAKENHI Grant Number 16H02657); Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI Grant Number 16K09694); and Grant-in-Aid for Young Scientists (B) (JSPS KAKENHI Grant Number 15K19492) from the Japan Society for the Promotion of Science. We thank Mitchell Arico from Edanz Group (www.edanzedit ing.com/ac) for editing a draft of this manuscript.
PY - 2019/2
Y1 - 2019/2
UR - http://www.scopus.com/inward/record.url?scp=85058048419&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058048419&partnerID=8YFLogxK
U2 - 10.1111/cen3.12488
DO - 10.1111/cen3.12488
M3 - Comment/debate
AN - SCOPUS:85058048419
VL - 10
SP - 7
EP - 8
JO - Clinical and Experimental Neuroimmunology
JF - Clinical and Experimental Neuroimmunology
SN - 1759-1961
IS - 1
ER -